雅虎香港 搜尋

登入

搜尋結果

  1. www.sanofi.comSanofi: global healthcare and pharmaceutical company

    2024年5月17日 · Sanofi X Paris 2024. We’re proud to be premium partner of Paris 2024. Science and sport aren’t that different. Just like athletes do, we overcome setbacks to keep moving forward, not just for ourselves, but for our patients, colleagues, families and friends. Read more about the partnership.

    • Our Company

      We want to build a healthier, more resilient world. We ...

    • Our Strategy

      We chase the miracles of science to improve ...

    • Our Legacy

      In 2023, Sanofi celebrated the 50 th anniversary of its ...

    • Your Health

      Your Health We chase the miracles of science to improve ...

    • Partnering

      Sanofi’s investment in Innate further validates ...

    • English

      Browse available job openings at Sanofi Global ...

  2. www.sanofi.co.jp › ja › media-room新生児および乳幼児のRSウイルス感染症による下気道疾患の発症抑 ...

    2024年5月22日 · 新生児および乳幼児のRSウイルス感染症による下気道疾患の発症抑制・予防薬ベイフォータス®新発売. 2024年5月22日. PDFをダウンロード.

  3. pharmacie-citypharma.fr › fr › lactacyd-soin-intim-lavant-400mlLACTACYD SOIN INTIM LAVANT 400ML | Pharmacie en ligne Citypharma

    2024年5月9日 · Riche en acide lactique naturel ainsi qu’en ingrédients régénérants, il confère une sensation fraîche et nourrissante, et vous aide à prévenir l’inconfort jour après jour. Peut être utilisé sous la douche ou dans le bain, comme un savon liquide, sur la muqueuse externe. Faites mousser, puis rincez abondamment à l’eau claire.

    • (1)
    • LACTACYD
    • A. Anonymous

  4. www.sanofi.com › en › investorsFourth quarter and full year 2019 - Sanofi

    5 天前 · Sanofi delivers strong 2019 business EPS growth of 6.8% at CER. Fourth quarter and full year 2019 results were reviewed by management during a conference call with the financial community. The presentation was followed by a Q&A session.

  5. www.sanofi.com › en › media-roomPress Release: Beyfortus real-world evidence published in ...

    2024年5月2日 · May 2, 2024. Download PDF. Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant RSV hospitalizations. New real-world evidence shows Beyfortus (nirsevimab) substantially reduced RSV lower respiratory tract disease and hospitalizations in infants during the 2023-2024 RSV season, versus no intervention 1-6.

  6. www.news.sanofi.us › 2024/05/10-FDA-approves-updatedPress Room - Sanofi US News

    2024年5月10日 · Customer Service. Media Contacts. FDA approves updated ALTUVIIIO® label with expanded pediatric data confirming highly effective bleed protection in children with hemophilia A. Full results from the pivotal XTEND-Kids study added to the US label, building on the interim data included in the 2023 FDA approval.

  7. siecledigital.fr › 2024/05/29 › sanofi-sassocie-avec-openaiSanofi s’associe avec OpenAI pour développer ...

    19 小時前 · Publié le 29 mai 2024 à 08h19. Mardi 21 mai 2024, le géant pharmaceutique Sanofi a annoncé un partenariat avec OpenAI, célèbre société derrière ChatGPT. La biotech Formation Bio fait également partie de l’aventure. Cette collaboration doit accélérer l’usage de l’intelligence artificielle (IA) dans le développement de ...